Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Nicotinamide–Ponatinib Analogu...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Nicotinamide–Ponatinib Analogues as Potent Anti-CML and Anti-AML Compounds

Bibliographic Details
Published in:ACS Omega
Main Authors: Elizabeth Larocque, Elizabeth Fei Yin Chu, Nimmashetti Naganna, Herman O. Sintim
Format: Article
Language:English
Published: American Chemical Society 2020-02-01
Online Access:https://doi.org/10.1021/acsomega.9b03223
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1021/acsomega.9b03223

Similar Items

  • DP131 | TREATMENT-FREE REMISSION AFTER PONATINIB: AN ITALIAN CAMPUS CML EXPERIENCE
    by: C. Fava, et al.
    Published: (2025-09-01)
  • P715: MULTICENTER OBSERVATIONAL STUDY OF PONATINIB IN CML PATIENTS IN ARGENTINA. REAL-WORLD EXPERIENCE.
    by: M. J. Mela Osorio, et al.
    Published: (2022-06-01)
  • S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
    by: Nikola Čuřík, et al.
    Published: (2023-08-01)
  • The Combination of Interferon-Alpha and Ponatinib Enables Faster and Deeper Molecular Responses in Patient with De Novo Blast Crisis of CML: Interferon-Alpha May Return as a CML Treatment
    by: Kunio Hayashi, et al.
    Published: (2021-01-01)
  • CASE REPORT: CML PROGRESSION TO AML-MR WITH CLONAL CHROMOSOMAL ABNORMALITIES
    by: S Lanes, et al.
    Published: (2023-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs